Purchases and Sales Made in Q4 2024 in Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX) during Q4 2024. The information is specifically focused on institutions that hold shares of RECURSION PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 31, 2025
Q4 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-376K- 1.49% |
$2.14M - $3.11M
|
24.9M
$169M
|
|
|
Feb 04, 2025
Q4 2024
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-423K- 1.29% |
$2.41M - $3.5M
|
32.3M
$220M
|
|
|
Feb 10, 2025
Q4 2024
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-786K- 8.11% |
$4.48M - $6.5M
|
8.91M
$60.5M
|
|
|
Jan 28, 2025
Q4 2024
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-786K- 8.05% |
$4.48M - $6.5M
|
8.98M
$61M
|
|
|
Feb 14, 2025
Q4 2024
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-7.66M- 49.79% |
$43.7M - $63.3M
|
7.73M
$52.5M
|